Daiichi Sankyo Pharmaceutical has launched silodosin for the treatment of dysuria associated with benign prostatic hyperplasia in China. Silodosin works by inhibiting the alpha 1A-adrenergic receptor and relieving tension in the prostate, ...
Tags: Daiichi Sankyo, Dysuria Therapy